Your browser doesn't support javascript.
loading
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.
Fewings, Eleanor; Larionov, Alexey; Redman, James; Goldgraben, Mae A; Scarth, James; Richardson, Susan; Brewer, Carole; Davidson, Rosemarie; Ellis, Ian; Evans, D Gareth; Halliday, Dorothy; Izatt, Louise; Marks, Peter; McConnell, Vivienne; Verbist, Louis; Mayes, Rebecca; Clark, Graeme R; Hadfield, James; Chin, Suet-Feung; Teixeira, Manuel R; Giger, Olivier T; Hardwick, Richard; di Pietro, Massimiliano; O'Donovan, Maria; Pharoah, Paul; Caldas, Carlos; Fitzgerald, Rebecca C; Tischkowitz, Marc.
Afiliação
  • Fewings E; Academic Laboratory of Medical Genetics, University of Cambridge, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK.
  • Larionov A; Academic Laboratory of Medical Genetics, University of Cambridge, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK.
  • Redman J; Academic Laboratory of Medical Genetics, University of Cambridge, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK.
  • Goldgraben MA; Academic Laboratory of Medical Genetics, University of Cambridge, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK.
  • Scarth J; Academic Laboratory of Medical Genetics, University of Cambridge, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK.
  • Richardson S; Familial Gastric Cancer Study, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Brewer C; Peninsula Clinical Genetics Service, Exeter, UK.
  • Davidson R; West of Scotland Genetics Services, Glasgow, UK.
  • Ellis I; Cheshire and Merseyside Regional Genetic Service, Liverpool, UK.
  • Evans DG; Manchester Centre for Genomic Medicine, Manchester, UK.
  • Halliday D; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Izatt L; Clinical Genetics Service, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Marks P; West Midlands Regional Genetics Service, Birmingham, UK.
  • McConnell V; Northern Ireland Regional Genetics Centre, Belfast City Hospital, Belfast, UK.
  • Verbist L; Department of Gastroenterology, ZNA Jan Palfijn, Antwerp, Belgium.
  • Mayes R; Centre for Cancer Genetic Epidemiology, Strangeway's Research Laboratory, University of Cambridge, Cambridge, UK.
  • Clark GR; Academic Laboratory of Medical Genetics, University of Cambridge, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK.
  • Hadfield J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Precision Medicine and Genomics, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Cambridge, UK.
  • Chin SF; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Teixeira MR; Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal; Institute of Biomedical Sciences, University of Porto, Porto, Portugal.
  • Giger OT; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Hardwick R; Department of Oesophago-Gastric Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • di Pietro M; Medical Research Council (MRC) Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK.
  • O'Donovan M; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Pharoah P; Centre for Cancer Genetic Epidemiology, Strangeway's Research Laboratory, University of Cambridge, Cambridge, UK.
  • Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK.
  • Fitzgerald RC; Medical Research Council (MRC) Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK.
  • Tischkowitz M; Academic Laboratory of Medical Genetics, University of Cambridge, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: mdt33@cam.ac.uk.
Lancet Gastroenterol Hepatol ; 3(7): 489-498, 2018 07.
Article em En | MEDLINE | ID: mdl-29706558
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Mutação em Linhagem Germinativa / Predisposição Genética para Doença / Proteína do Grupo de Complementação N da Anemia de Fanconi Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Mutação em Linhagem Germinativa / Predisposição Genética para Doença / Proteína do Grupo de Complementação N da Anemia de Fanconi Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido